Rare Disease Registries: Practical Ways to Build Trust with Patient Advocacy Groups

1:02:03

With the right planning and understanding, collaboration between drug development companies and patient advocacy groups (PAGs) can be mutually beneficial in a number of key areas.

View More
View Less

Share this video

Embed